Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-061052

Director bought 5,000 shares at $6.55 ($32,750)

From the SEC's structured data for this filing

Trades in this filing

Hochman David P · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Purchase : show line 1 in the form +5,000 $6.55 $32,750 220,000 I
Open-market purchases · 5,000 sh · avg $6.55 · $32,750
Loading xslF345X03/doc4.xml…